Report Code : CVMI2412268 | Published Date : March 3, 2025
The Global Artificial Insemination Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.3 billion by 2031, growing at a CAGR of 9.2%. The market is expanding due to rising infertility rates, advancements in assisted reproductive technology (ART), and an increasing acceptance of AI procedures in both humans and livestock.
2024 Market Breakthroughs
- Human AI Innovations:
- Vitrolife’s AI Sperm Selection System improves pregnancy rates by 22% through AI-based morphology analysis.
- CooperSurgical’s Gavi® Sperm Prep reduces DNA fragmentation by 30%, which enhances fertilization success.
- Livestock AI Advancements:
- STgenetics’ SexedULTRA™ achieves 95% accuracy in gender selection for cattle breeding.
- ABS Global’s InForce™ extends sperm viability to 72 hours post-thawing.
- Regulatory & Tech Shifts:
- FDA approves AI-powered semen analyzers for at-home fertility testing (2024).
- EU’s Animal Breeding Regulation mandates genomic screening for all AI livestock semen.
Market Drivers
- Rising Infertility Rates
- 1 in 6 couples globally face infertility (WHO, 2024).
- Delayed parenthood trends (avg. first-time mothers now 31.5 years in developed nations).
- Livestock Industry Demand
- Dairy sector drives 60% of livestock AI market (high-yield breeding).
- Pork & poultry industries adopt AI to improve genetic traits.
- Technological Advancements
- AI-based sperm selection increases IVF success rates.
- Cryopreservation tech improves post-thaw sperm survival.
Competitive Landscape
Company |
Market Share |
Flagship Innovation |
Strategic Edge |
CooperSurgical |
28% |
Gavi® Sperm Prep |
Leading human fertility segment |
STgenetics |
22% |
SexedULTRA™ gender-sorted semen |
Livestock AI dominance |
Vitrolife |
XX% |
AI Sperm Selection System |
High IVF clinic adoption |
Emerging Disruptors:
- TMRW Life Sciences: Automated cryo-storage for AI samples (Series C: USD 75M).
- Mojo Fertility: At-home AI sperm testing kit (FDA-cleared, 2024).
Market Segmentation
- By Type:
- Intrauterine Insemination (IUI) (55%) – Most common human AI procedure.
- Intracervical Insemination (ICI) (XX%) – Lower-cost alternative.
- Livestock AI (XX%) – Fastest-growing (12% CAGR).
- By End-User:
- Fertility Clinics (XX%) – High adoption of advanced AI tech.
- Home Insemination (XX%) – Rising due to telehealth & at-home kits.
- Animal Breeding (XX%) – Dairy & poultry industries dominate.
- By Region:
- North America (35%) – High IVF adoption & advanced livestock AI.
- Europe (XX%) – Strict regulations drive premium AI solutions.
- Asia-Pacific (XX%) – Rapidly growing due to rising infertility rates.
Recent Developments (2024)
- May 2024: FDA approves first AI-powered at-home semen analyzer (Mojo Fertility).
- July 2024: ABS Global partners with CRISPR firms for gene-edited livestock semen.
Reasons To Buy

Scope

Key Players
- Artificial Insemination Market – Genus plc
- CRV Holding B.V.
- URUS Group LP
- Topigs Norsvin
- Select Sires Inc.
- ABS Global Inc.
- Semex
- IMV Technologies
- Zoetis Inc.
- Animal Genetics Inc.
Global Artificial Insemination Market Report
- 1. Global Artificial Insemination Market Research Report
- 1.1 Study Objectives
- 1.2 Global Artificial Insemination Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Artificial Insemination Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type
- 2.1.2 By Application
- 2.1.3 By End-user
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type, By Application, By End-user, By Country
- 3.3. Opportunities – By Type, By Application, By End-user, By Country
- 3.4. Trends – By Type, By Application, By End-user, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Artificial Insemination Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Sperm Donation
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Oocyte Donation
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Livestock Breeding
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Human Fertility
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Fertility Clinics
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Veterinary Clinics.
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.6 Global Artificial Insemination Market - Opportunity Analysis Index, By Type, By Application, By End-user, and Region, 2024 - 2031
- 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Sperm Donation
- 9.1.2 Oocyte Donation
- 9.2.1 Livestock Breeding
- 9.2.2 Human Fertility
- 9.3.1 Hospitals
- 9.3.2 Fertility Clinics
- 9.3.3 Veterinary Clinics.
- 9.4.1 United States
- 9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Artificial Insemination Market Research Report - Company Profiles- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Sperm Donation
- 10.1.2 Oocyte Donation
- 10.2.1 Livestock Breeding
- 10.2.2 Human Fertility
- 10.3.1 Hospitals
- 10.3.2 Fertility Clinics
- 10.3.3 Veterinary Clinics.
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands
- 10.4.8 Poland
- 10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Artificial Insemination Market Research Report - Company Profiles- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Sperm Donation
- 11.1.2 Oocyte Donation
- 11.2.1 Livestock Breeding
- 11.2.2 Human Fertility
- 11.3.1 Hospitals
- 11.3.2 Fertility Clinics
- 11.3.3 Veterinary Clinics.
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & NZ
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Artificial Insemination Market Research Report - Company Profiles- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Sperm Donation
- 12.1.2 Oocyte Donation
- 12.2.1 Livestock Breeding
- 12.2.2 Human Fertility
- 12.3.1 Hospitals
- 12.3.2 Fertility Clinics
- 12.3.3 Veterinary Clinics.
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Artificial Insemination Market Research Report - Company Profiles- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Sperm Donation
- 13.1.2 Oocyte Donation
- 13.2.1 Livestock Breeding
- 13.2.2 Human Fertility
- 13.3.1 Hospitals
- 13.3.2 Fertility Clinics
- 13.3.3 Veterinary Clinics.
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Artificial Insemination Market Research Report - Company Profiles- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 14.2.1 Artificial Insemination Market – Genus plc
- 14.2.2 CRV Holding B.V.
- 14.2.3 URUS Group LP
- 14.2.4 Topigs Norsvin
- 14.2.5 Select Sires Inc.
- 14.2.6 ABS Global Inc.
- 14.2.7 Semex
- 14.2.8 IMV Technologies
- 14.2.9 Zoetis Inc.
- 14.2.10 Animal Genetics Inc.
16. Principal Presumptions and Acronyms